A detailed history of Franchise Capital LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Franchise Capital LTD holds 23,418 shares of NVO stock, worth $2.05 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
23,418
Previous 136,172 82.8%
Holding current value
$2.05 Million
Previous $19.4 Million 85.66%
% of portfolio
1.0%
Previous 4.7%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$119.07 - $145.42 $13.4 Million - $16.4 Million
-112,754 Reduced 82.8%
23,418 $2.79 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $871,406 - $1.16 Million
8,534 Added 6.69%
136,172 $17.5 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $5.32 Million - $6.39 Million
60,582 Added 90.35%
127,638 $13.2 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $6.1 Million - $13.4 Million
67,056 New
67,056 $6.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Franchise Capital LTD Portfolio

Follow Franchise Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franchise Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Franchise Capital LTD with notifications on news.